Annie Pardo
- Dehydroepiandrosterone has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosisBy Criselda Mendoza-Milla, Ana Valero Jiménez, Claudia Rangel, Alfredo Lozano, Violeta Morales, Carina Becerril, Roberto Chavira, Víctor Ruiz, Lourdes Barrera, Martha Montaño, Annie Pardo and Moisés SelmanCriselda Mendoza-Milla1Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico CityAna Valero Jiménez1Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico CityClaudia Rangel2Instituto Nacional de Medicina Genómica, Mexico CityAlfredo Lozano1Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico CityVioleta Morales1Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico CityCarina Becerril1Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico CityRoberto Chavira3Instituto Nacional de Ciencias Médicas y de la Nutrición “Salvador Zubirán”, Mexico CityVíctor Ruiz1Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico CityLourdes Barrera1Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico CityMartha Montaño1Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico CityAnnie Pardo4Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City, MexicoMoisés Selman1Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City
- DHEA has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosisBy Criselda Mendoza, Ana Valero Jiménez, Claudia Rangel, Alfredo Lozano, Violeta Morales, Carina Becerril, Roberto Chavira, Víctor Ruiz, Lourdes Barrera, Martha Montaño, Annie Pardo and Moisés SelmanArticle | Published in 2012 in European Respiratory JournalCriselda Mendoza*Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, MéxicoAna Valero Jiménez*Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, MéxicoClaudia Rangel#Instituto Nacional de Medicina GenómicaAlfredo Lozano*Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, MéxicoVioleta Morales*Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, MéxicoCarina Becerril*Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, MéxicoRoberto Chavira¶Instituto Nacional de Ciencias Médicas y de la Nutrición "Salvador Zubirán"Víctor Ruiz*Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, MéxicoLourdes Barrera*Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, MéxicoMartha Montaño*Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, MéxicoAnnie Pardo+Facultad de Ciencias, Universidad Nacional Autónoma de MéxicoMoisés Selman*Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, México
- Increased alveolar soluble annexin V promotes lung inflammation and fibrosisBy Susan Buckley, Wei Shi, Wei Xu, Mark R. Frey, Rex Moats, Annie Pardo, Moises Selman and David WarburtonArticle | Published in 2015 in European Respiratory JournalSusan Buckley1Developmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USAWei Shi1Developmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USAWei Xu1Developmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USAMark R. Frey1Developmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USARex Moats2Imaging Core Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USAAnnie Pardo3Facultad de Ciencias, Universidad Nacional Autónoma de México, México DF, MéxicoMoises Selman4Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas” , México DF, MéxicoDavid Warburton1Developmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA
- Increased alveolar soluble annexin V promotes lung inflammation and fibrosisBy Susan Buckley, Wei Shi, Wei Xu, Mark R. Frey, Rex Moats, Annie Pardo, Moises Selman and David WarburtonSusan Buckley1Developmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USAWei Shi1Developmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USAWei Xu1Developmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USAMark R. Frey1Developmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USARex Moats2Imaging Core Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USAAnnie Pardo3Facultad de Ciencias, Universidad Nacional Autónoma de México, México DF, MéxicoMoises Selman4Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, México DF, MéxicoDavid Warburton1Developmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.